⌘K

Login Start Free

Home/Filings/4/0000899243-21-009235

4//SEC Filing

Chang David J. 4

Accession 0000899243-21-009235

CIK 0001759138other

View on SEC.gov Company Profile

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 9:47 PM ET

Size

5.4 KB

Accession

0000899243-21-009235

Insider Transaction Report

Form 4

Period: 2021-03-01

Cabaletta Bio, Inc.CABA

Chief Medical Officer

Transactions

Award
Stock Option (Right to Buy)
2021-03-01+113,500→ 113,500 total
Exercise: $11.47Exp: 2031-02-28→ Common Stock (113,500 underlying)

Footnotes (1)

[F1]This option vests over four years, with 25% vesting on March 1, 2022 and the remaining shares vesting in 12 equal quarterly installments thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cabaletta Bio, Inc.

CIK 0001759138

Entity typeother

Related Parties

1

filerCIK 0001790552

Filing Metadata

Form type: 4
Filed: Mar 1, 7:00 PM ET
Accepted: Mar 2, 9:47 PM ET
Size: 5.4 KB

View on SEC.gov